Pilot open label clinical trial with abatacept in ankylosing spondylitis
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Abatacept (Primary)
- Indications Ankylosing spondylitis
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 04 Jun 2013 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
- 25 Feb 2008 Status changed from initiated to recruiting.